Sera Prognostics (SERA) Net Cash Flow (2020 - 2026)
Sera Prognostics (SERA) posted Net Cash Flow of $231000.0 for Q1 2026, up 268.61% on a QoQ basis from -$137000.0 in Q4 2025, and down 80.54% year-over-year from $1.2 million in Q1 2025.
Sera Prognostics (SERA) Net Cash Flow (2020 - 2026) Analysis & Trends
Sera Prognostics' Net Cash Flow history runs 7 years deep, the most recent figure standing at $231000.0 for Q1 2026.
- Quarterly Net Cash Flow fell 80.54% year-over-year to $231000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.1 million (down 206.46% YoY) and the FY2025 annual result came in at -$99000.0, down 160.74% from the prior year.
- Net Cash Flow was $231000.0 for Q1 2026 at Sera Prognostics, up from -$137000.0 in the prior quarter.
- Across five years, Net Cash Flow topped out at $5.1 million in Q1 2022 and bottomed at -$22.6 million in Q3 2023.
- A 5-year average of -$3.2 million and a median of -$214000.0 in 2025 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2023 — Net Cash Flow tumbled 152.0% — and 2025, when it surged 230.64%.
- Sera Prognostics' Net Cash Flow stood at -$8.9 million in 2022, then soared by 35.34% to -$5.8 million in 2023, then soared by 123.53% to $1.4 million in 2024, then sank by 110.08% to -$137000.0 in 2025, then surged by 268.61% to $231000.0 in 2026.
- Business Quant data shows SERA's Net Cash Flow at $231000.0 in Q1 2026, -$137000.0 in Q4 2025, and -$935000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -500.20 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 202.10 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.19 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -282.15 Mn |
| 10 | Sera Prognostics | 105.54 Mn | 105.54 Mn | -28,000.00 | 231,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 231,000.00 |
| Mar 31, 2026 | 231,000.00 |
| Dec 31, 2025 | -137,000.00 |
| Dec 31, 2025 | -137,000.00 |
| Sep 30, 2025 | -935,000.00 |
| Sep 30, 2025 | -935,000.00 |
| Jun 30, 2025 | -214,000.00 |
| Jun 30, 2025 | -214,000.00 |
| Mar 31, 2025 | 1.19 Mn |
| Mar 31, 2025 | 1.19 Mn |
| Dec 31, 2024 | 1.36 Mn |
| Dec 31, 2024 | 1.36 Mn |
| Sep 30, 2024 | -1.98 Mn |
| Sep 30, 2024 | -1.98 Mn |
| Jun 30, 2024 | 425,000.00 |
| Jun 30, 2024 | 425,000.00 |
| Mar 31, 2024 | 359,000.00 |
| Mar 31, 2024 | 359,000.00 |
| Dec 31, 2023 | -5.78 Mn |
| Dec 31, 2023 | -5.78 Mn |